J Drugs Dermatol
-
Randomized Controlled Trial
A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis.
Crisaborole is a novel, boron-based, small-molecule, topical phosphodiesterase-4 inhibitor in development for the treatment of patients with mild to moderate atopic dermatitis (AD). ⋯ These results provide preliminary evidence of the efficacy and safety of crisaborole topical ointment, 2% applied topically BID in adolescents with mild to moderate AD.
-
Randomized Controlled Trial
Lip and Perioral Enhancement: A 12-Month Prospective, Randomized, Controlled Study.
Juvéderm® Volbella® with Lidocaine is a hyaluronic acid filler suited for lip enhancement. ⋯ Juvéderm Volbella with Lidocaine is safe and effective for lip and perioral enhancement, with effectiveness lasting up to 12 months.